Guardant Health, Inc. (GH) Dividend History

Company News

• Epigenetics Market Anticipated to Achieve 11.8% CAGR

  The global epigenetics market is projected to grow from $4.8 billion in 2024 to $8.5 billion by 2029, driven by factors like rising cancer rates, technological advances, and the trend towards precision medicine.

  GlobeNewswire Inc.

  Featured Companies: BIO BIO.B BMY EXAS HOLX
• Guardant Health: A Promising Player in the Liquid Biopsy Market

  The Motley Fool is a financial services company founded in 1993, dedicated to making the world smarter, happier, and richer. It reaches millions of people through its premium investing solutions, free guidance, market analysis, personal finance education, top-rated podcasts, and non-profit foundation.

  The Motley Fool
• Guardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform

  Guardant Health and Pfizer have announced a strategic collaboration to use Guardant's liquid biopsy platform in Pfizer's oncology clinical trials, including monitoring circulating tumor DNA as a therapy response marker. The collaboration will also allow Pfizer to access Guardant's liquid biopsy tests in China.

  Benzinga

  Featured Companies: PFE
• Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide

  The Minimal Residual Disease (MRD) Testing Market is expected to grow at a CAGR of 11.18% from 2025 to 2030, driven by advancements in diagnostic technologies and the increasing focus on precision medicine and early relapse detection.

  GlobeNewswire Inc.

  Featured Companies: ADPT AMGN BIO BIO.B BMY DGX EXAS GILD ILMN LH MDXH MYGN NEO NTRA OPK TECH VCYT
• Cancer Biomarkers Research Report 2024: Global Market Projected to Soar to USD 62.14 Billion by 2034, Driven by Technological Advancements and Increasing Demand for Early Detection

  The global cancer biomarkers market is projected to grow from $15.09 billion in 2023 to $62.14 billion by 2034, driven by advancements in technology, increasing demand for early cancer detection, and the growing incidence of cancer cases globally.

  GlobeNewswire Inc.

  Featured Companies: A ABT BIO BIO.B BMY EXAS ILMN MYGN QGEN TMO